Tumor progression: potential role of unstable genomic changes
- PMID: 2253313
- DOI: 10.1007/BF00046340
Tumor progression: potential role of unstable genomic changes
Abstract
It is generally accepted that the genome of tumor cells is less stable than that of most normal cells, and it has been hypothesized that this genomic instability is probably involved in the process of tumor progression. However, the rate of occurrence of classical spontaneous mutations in tumor cells is too low to account for the rapid changes that can occur during tumor progression. Thus it is likely that other types of changes, such as gene amplification, must be involved in tumor progression. Gene amplification has been extensively studied in relation to the development of drug resistance. Low levels of amplification can occur spontaneously in tumor cell populations, but the amplified genes are lost rapidly unless prolonged selective pressure is applied. This paper argues that unstable increases in the expression of genes, probably as a result of low levels of amplification, may be all that is required for some of the stages in the process of tumor progression. This may be particularly true for the steps involved in metastasis formation. Recent studies have suggested that microenvironmental conditions known to occur in tumors (hypoxia, nutrient deprivation) may induce gene amplification in cells. This suggests the possibility that such conditions could promote tumor progression.
Similar articles
-
Role of proto-oncogene activation in carcinogenesis.Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813. Environ Health Perspect. 1992. PMID: 1486840 Free PMC article. Review.
-
Metastasis-Associated genes and metastatic tumor progression.In Vivo. 1998 Nov-Dec;12(6):579-88. In Vivo. 1998. PMID: 9891220 Review.
-
A perspective on tumour progression.Can J Surg. 1993 Apr;36(2):133-6. Can J Surg. 1993. PMID: 8472222 Review.
-
Overexpression and amplification of c-myc during progression of human colorectal cancer.Oncology. 1996 Nov-Dec;53(6):448-54. doi: 10.1159/000227619. Oncology. 1996. PMID: 8960139
-
Gene amplification and tumor progression.Biochim Biophys Acta. 1993 May 25;1155(1):25-41. doi: 10.1016/0304-419x(93)90020-d. Biochim Biophys Acta. 1993. PMID: 8504129 Review.
Cited by
-
Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compounds.Curr Oncol Rep. 2005 Mar;7(2):90-5. doi: 10.1007/s11912-005-0033-x. Curr Oncol Rep. 2005. PMID: 15717941 Review.
-
Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.Br J Cancer. 1994 Nov;70(5):804-12. doi: 10.1038/bjc.1994.403. Br J Cancer. 1994. PMID: 7947084 Free PMC article.
-
CINSARC: a new look into an old concept gives hope for new treatments for synovial sarcomas.Transl Pediatr. 2013 Apr;2(2):70-2. doi: 10.3978/j.issn.2224-4336.2013.04.04. Transl Pediatr. 2013. PMID: 26835293 Free PMC article. No abstract available.
-
Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro.Br J Cancer. 1997;76(4):421-8. doi: 10.1038/bjc.1997.405. Br J Cancer. 1997. PMID: 9275017 Free PMC article.
-
The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30(3):189-224. doi: 10.1080/10590501.2012.705159. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012. PMID: 22970719 Free PMC article. Review.